Alere (NYSE:ALR) declared on Thursday that it will pay a dividend of USD3.00 per share on its Series B convertible perpetual preferred stock (NYSE:ALR.PR.B).

This cash dividend is due on 15 July 2016 to holders of record of Series B stock at the close of business as of 1 July 2016.

The company added that the payment will cover the amount of all dividends accrued from 1 April 2016 through 30 June 2016.

Headquartered in Waltham, Mass., the company focuses on rapid diagnostics for infectious disease, cardiometabolic disease and toxicology as well as provides reliable and actionable information through rapid diagnostic tests, enhancing clinical and economic health outcomes globally.